Rise in the geriatric population, surge in healthcare expenditure, and rise in prevalence of hypertension across the globe drive the growth of the global market

PORTLAND, OREGON, UNITED STATES, October 18, 2021 /EINPresswire.com/ -- According to the report by Allied Market Research, titled, "Antihypertensive Drugs Market by Therapeutic Class (Diuretics, ACE Inhibitors, Calcium Channel Blockers, Vasodilators, Beta-adrenergic Blockers, and Others) and Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-commerce, and Others Distribution Channel): Global Opportunity Analysis and Industry Forecast, 2019–2026". The report provides a detailed analysis of changing market dynamics, top segments, value chain, key investment pockets, regional scenario, and competitive landscape.

Rise in the geriatric population, surge in healthcare expenditure, and rise in prevalence of hypertension across the globe drive the growth of the global antihypertensive drugs market. However, patent expirations of blockbuster drugs hamper the market growth. On the contrary, high growth potential in developing countries is expected to create lucrative opportunities in the near future.

Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/436

The antihypertensive drugs industry was pegged at $22.56 billion in 2018, and is estimated to reach $28.79 billion by 2026, growing at a CAGR of 3.1% from 2019 to 2026.

Comprehensive competitive analysis and profiles of major market players, such as:

Boehringer Ingelheim GmbH
Johnson and Johnson
Merck KGaA
Pfizer, Inc.
Bayer AG
AstraZeneca plc
Takeda Pharmaceutical Co., Ltd.
Sanofi S.A.
Daiichi Sankyo Company
Novartis International AG

Increase in geriatric population worldwide, rise in healthcare expenditure worldwide, and surge in prevalence of hypertension across the globe have augmented the growth of the global antihypertensive drugs market. Whereas, patent expirations of blockbuster drugs impede the market growth. On the other hand, high growth potential in developing economies is projected to provide lucrative opportunities in the near future.

The hospital pharmacy segment held the largest share

The hospital pharmacy segment dominated the market in 2018, accounting for more than half of the global antihypertensive drugs market, owing to increase in the number of hospitalized NASH patients, surge in number of hospital pharmacies, improvement in structure of hospital pharmacies in the emerging countries such as China and India. However, the e-commerce websites & online drug stores segment is projected to register the fastest CAGR of 4.2% during the study period, due to surge in preference for online purchasing of drugs over the traditional methods, rise in the number of Internet users, and increase in awareness of online pharmacy.

For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/436

Key Benefits For Stakeholders:

• The study provides an in-depth analysis of the Antihypertensive Drugs Market along with the current trends and future estimations to elucidate the imminent investment pockets.

• It offers Antihypertensive Drugs Market analysis from 2020 to 2026, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.

• A comprehensive analysis of four regions is provided to determine the prevailing opportunities.

• The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global Antihypertensive Drugs Market growth.

FREQUENTLY ASKED QUESTIONS?

Q1. What is the market value of Antihypertensive Drugs Market report in forecast period?
Q2. What would be forecast period in the market report?
Q3. What is the market value of Antihypertensive Drugs Market in 2020?
Q4. Which is base year calculated in the Antihypertensive Drugs Market report?
Q5. Does the Antihypertensive Drugs Market company is profiled in the report?
Q6. Which are the top companies hold the market share in Antihypertensive Drugs Market?
Q7. Does the Antihypertensive Drugs Market report provides Value Chain Analysis?
Q8. What are the key trends in the Antihypertensive Drugs Market report?

Avenue Basic Plan | Library Access | 1 Year Subscription |

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

Request for 14 days free trial: https://www.alliedmarketresearch.com/avenue/trial/starter

“We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.”

Trending Reports in Healthcare Industry (Book Now with 10% Discount):

Autoimmune Disease Therapeutics Market - Global Opportunity Analysis and Industry Forecast, 2020–2028

Oncology/Cancer Drugs Market - Global Opportunity Analysis and Industry Forecast, 2019-2028

Australia & New Zealand Fertility Services Market - Global Opportunity Analysis and Industry Forecast, 2019-2028

About Us:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

David Correa
Allied Analytics LLP
+18007925285 ext.
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn